Baotou Dongbao Bio-Tech Co.,Ltd (300239.SZ)
CNY 5.53
(-0.36%)
CNY 5.53
(-0.36%)
| Breakdown | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 |
|---|---|---|---|---|---|---|
| Operating Cash Flow | 199.39 Million | 195.31 Million | 51.5 Million | 63.12 Million | -41.63 Million | 60 Million |
| Net Income | 127.37 Million | 115.43 Million | 35.82 Million | 18.19 Million | 35.6 Million | 33.97 Million |
| Depreciation & Amortization | 81.96 Million | 85.51 Million | 55.31 Million | 48.69 Million | 35.35 Million | 36.13 Million |
| Deferred income taxes | -3.91 Million | -3.39 Million | -107.06 Thousand | -1.86 Million | -641.51 Thousand | -4.51 Million |
| Stock-based compensation | - | - | - | - | - | 677.22 Thousand |
| Change in working capital | -21.82 Million | -14.84 Million | -41.8 Million | -8.89 Million | -112.76 Million | -16.31 Million |
| Other non-cash items | 7.27 Million | 9.21 Million | 2.16 Million | 5.14 Million | 176.33 Thousand | 6.2 Million |
| Investing Cash Flow | -130.41 Million | -224.16 Million | -168.44 Million | -158.99 Million | -139.32 Million | -58.17 Million |
| Investments in PPE | -132.24 Million | -108.56 Million | -51.35 Million | -151.92 Million | -129.36 Million | -55.23 Million |
| Acquisitions | 541.41 Thousand | -122.33 Million | -108.07 Million | 7.52 Million | 79.48 Thousand | - |
| Investment purchases | -303 Million | 822.88 Thousand | -11.53 Million | -7.09 Million | -10.04 Million | -2.94 Million |
| Sales/Maturities of investments | 303 Million | 4.67 Million | 947.66 Thousand | -7.52 Million | -79.48 Thousand | - |
| Other Investing Activities | 1.59 Million | 1.23 Million | 1.56 Million | 27.51 Thousand | 79.48 Thousand | -55.23 Million |
| Financing Cash Flow | 305.86 Million | 175.08 Million | 261.03 Million | 89.62 Million | 167.75 Million | 11.13 Million |
| Debt repayment | -299.06 Million | -67.1 Million | -209.8 Million | -41.5 Million | -75 Million | -7.7 Million |
| Dividends payments | -15.43 Million | -3.56 Million | -5.73 Million | -15.68 Million | -15.71 Million | -12.76 Million |
| Common Stock Repurchased | - | - | -2.68 Million | -2.58 Million | -3.38 Million | - |
| Common Stock Issuance | - | - | 2.68 Million | 2.58 Million | 3.38 Million | 8.45 Million |
| Other Financing Activities | 28.08 Million | 253.39 Million | 476.56 Million | 151.71 Million | 262.28 Million | 31.6 Million |
| Accounts receivables | -52.76 Million | -45.12 Million | -62.48 Million | 27.9 Million | -40 Million | -103.36 Million |
| Accounts payables | -3.01 Million | 5.31 Million | 14.4 Million | 20.29 Million | -69.43 Million | 166.24 Million |
| Inventory | 37.86 Million | 28.35 Million | 6.37 Million | -55.23 Million | -1.3 Million | -74.68 Million |
| Other working capital | -3.5 Million | -3.39 Million | -107.06 Thousand | -1.86 Million | -2.03 Million | 58.36 Million |
| Cash at beginning of period | 338.45 Million | 191.88 Million | 47.79 Million | 54.03 Million | 67.14 Million | 54.18 Million |
| Cash at end of period | 713.45 Million | 338.45 Million | 191.88 Million | 47.79 Million | 53.94 Million | 67.14 Million |
| Capital Expenditure | -132.24 Million | -108.56 Million | -51.35 Million | -151.92 Million | -129.36 Million | -55.23 Million |
| Effect of forex changes on cash | 141.12 Thousand | 344.18 Thousand | -11.26 Thousand | - | 7135.23 | 0.45 |
| Net cash flow / Change in cash | 374.99 Million | 146.57 Million | 144.08 Million | -6.24 Million | -13.2 Million | 12.96 Million |
| Free Cash Flow | 67.15 Million | 86.75 Million | 149.96 Thousand | -88.79 Million | -171 Million | 4.76 Million |
| Breakdown | 2024 Q2 | 2024 Q1 | 2023 FY | 2023 Q4 | 2023 Q3 | 2023 Q2 |
|---|---|---|---|---|---|---|
| Operating Cash Flow | - | - | - | - | - | - |
| Net Income | 25.38 Million | 25.96 Million | 127.37 Million | 24.62 Million | 30.25 Million | 33.86 Million |
| Depreciation & Amortization | 21.02 Million | 21.02 Million | 81.96 Million | 81.96 Million | -41.24 Million | 20.82 Million |
| Deferred income taxes | - | - | -3.91 Million | - | - | - |
| Stock-based compensation | - | - | - | - | - | - |
| Change in working capital | - | - | -21.82 Million | -18.4 Million | 36.97 Million | -36.97 Million |
| Other non-cash items | 68.3 Million | -35.36 Million | 7.27 Million | -19.07 Million | 87.47 Million | 21.12 Million |
| Investing Cash Flow | -9.65 Million | 9.15 Million | -130.41 Million | -54.32 Million | -34.35 Million | -31.02 Million |
| Investments in PPE | -10.64 Million | -24.06 Million | -132.24 Million | -55.96 Million | -34.38 Million | -31.16 Million |
| Acquisitions | -2.11 Million | 33.22 Million | 541.41 Thousand | 101.37 Thousand | 79.91 Thousand | 145.12 Thousand |
| Investment purchases | -511 Million | - | -303 Million | -303 Million | - | - |
| Sales/Maturities of investments | 511 Million | - | 303 Million | 303 Million | - | - |
| Other Investing Activities | 994.01 Thousand | 33.22 Million | 1.59 Million | 1.64 Million | -49.99 Thousand | 0.37 |
| Financing Cash Flow | -20.24 Million | 2.6 Million | 305.86 Million | -14.28 Million | 385.24 Million | -16.94 Million |
| Debt repayment | -8 Million | -3 Million | -299.06 Million | -43.47 Million | -55.2 Million | - |
| Dividends payments | -13.8 Million | -397.65 Thousand | -15.43 Million | -15.43 Million | -1.39 Million | -16.94 Million |
| Common Stock Repurchased | - | - | - | - | - | - |
| Common Stock Issuance | - | - | - | - | - | - |
| Other Financing Activities | -13.52 Million | -397.65 Thousand | 28.08 Million | 30.08 Million | 441.84 Million | -16.94 Million |
| Accounts receivables | - | - | -52.76 Million | -52.76 Million | 74.47 Million | -74.47 Million |
| Accounts payables | - | - | -3.01 Million | - | - | - |
| Inventory | - | - | 37.86 Million | 37.86 Million | -37.12 Million | 37.12 Million |
| Other working capital | - | - | -3.5 Million | -3.5 Million | -376.35 Thousand | 376.35 Thousand |
| Cash at beginning of period | 715.78 Million | 736.07 Million | 338.45 Million | 712.93 Million | 248.57 Million | 257.63 Million |
| Cash at end of period | 755.4 Million | 759.89 Million | 713.45 Million | 713.45 Million | 712.93 Million | 248.57 Million |
| Capital Expenditure | -10.64 Million | -24.06 Million | -132.24 Million | -55.96 Million | -34.38 Million | -31.16 Million |
| Effect of forex changes on cash | -33.97 Thousand | -8836.51 | 141.12 Thousand | 18.79 Thousand | 25.22 Thousand | 70.94 Thousand |
| Net cash flow / Change in cash | 39.61 Million | 23.81 Million | 374.99 Million | 511.6 Thousand | 464.36 Million | -9.05 Million |
| Free Cash Flow | 62.01 Million | -33.47 Million | 67.15 Million | 13.13 Million | 79.06 Million | 7.67 Million |
7937
4498
ANSCW
GJST
SFIN
TWR